Market Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference

[PR Newswire] – TARRYTOWN, N.Y. and PARIS, May 18, 2015 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi today shared positive results from an interim analysis of a pivotal Phase 2b study of . . . → Read More: Market Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference Similar Articles: Company Update (NASDAQ:REGN): Regeneron Reports First Quarter 2015 Financial and Operating Results Stock Update (NASDAQ:REGN): Regeneron Announces Upcoming 2015 Investor Conference Presentations Company Update (NASDAQ:REGN): Regeneron to Report First Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on May 7, 2015